Skip to main content
Krakchemia S.A. logo

Krakchemia S.A. — Investor Relations & Filings

Ticker · KCH ISIN · PLKRKCH00019 LEI · 259400QGYEAGRYCQ5Y56 WAR Wholesale and retail trade
Open in API
Filings indexed 587 across all filing types
Latest filing 2018-03-30 Audit Report / Informat…
Country PL Poland
Listing WAR KCH

About Krakchemia S.A.

https://www.krakchemia.pl/en

Krakchemia S.A. is a distributor specializing in the wholesale trade of chemical products and plastics. The company's core offerings include a wide range of plastic raw materials, such as granules, and various types of packaging films. Its product portfolio also encompasses laboratory chemicals, reagents, and other chemical raw materials for industrial and commercial applications. The company provides value-added services, including the slitting and rewinding of films, utilizing modern machinery for materials intended for food contact.

Recent filings

Filing Released Lang Actions
Sprawozdanie z działalności KRAKCHEMIA SA za 2017 rok zawierające: oświadczenie zarządu dotyczące sporządzonego rocznego sprawozdania finansowego i sprawozdania z działalności, oświadczenie zarząd...
Audit Report / Information Classification · 98% confidence The document is titled "SPRAWOZDANIE Z DZIAŁALNOŚCI KRAKCHEMIA S.A. za 2017 rok" which translates to "Activity Report of KRAKCHEMIA S.A. for the year 2017". It contains a detailed table of contents covering governance, operations, risk factors, and financial reporting principles, which are characteristic features of a comprehensive annual report. Although the text is in Polish, the structure and content strongly align with the requirements for an Annual Report, which corresponds to the US SEC's 10-K filing, or its local equivalent for comprehensive annual disclosures. Given the provided definitions, 'Annual Report (Code: 10-K)' is the most appropriate classification for a full-year activity and financial report. FY 2017
2018-03-30 Polish
Sprawozdanie finansowe za 2017 rok
Audit Report / Information Classification · 98% confidence The document is explicitly titled "SPRAWOZDANIE FINANSOWE ZA ROK 2017" (Financial Report for the Year 2017) and contains a detailed 'INDEKS DO SPRAWOZDANIA FINANSOWEGO' (Index to the Financial Report) listing components like 'SPRAWOZDANIE Z ZYSKU LUB STRATY I INNYCH CAŁKOWITYCH DOCHODÓW' (Statement of Profit or Loss and Other Comprehensive Income), 'SPRAWOZDANIE Z SYTUACJI FINANSOWEJ' (Statement of Financial Position), and extensive notes based on IFRS ('MSSF'). This structure and content clearly indicate a comprehensive annual financial statement, which aligns with the definition of an Annual Report (10-K), although the document is Polish and not explicitly an SEC Form 10-K, the content matches the scope of an annual report. Given the provided definitions, '10-K' is the closest match for a full annual financial report. FY 2017
2018-03-30 Polish
Pismo Prezesa Zarządu
Report Publication Announcement Classification · 99% confidence The document is explicitly titled as a 'raport roczny spółki KRAKCHEMIA S.A. za 2017 rok' (annual report of KRAKCHEMIA S.A. for 2017) and contains a detailed review of the past year's financial performance, operational activities, challenges (like loss on operations, impact of parent company bankruptcy, loss of credit lines), and future strategic goals. This content aligns perfectly with the definition of an Annual Report, which is typically filed as a 10-K in the US context, but given the Polish context and the description provided, the closest match for a comprehensive yearly report is '10-K'. The date of the letter (March 30, 2018) is consistent with the filing of a 2017 annual report. Although it is a letter from the CEO accompanying the report, the core subject matter is the full annual report itself, not just an announcement of its publication (RPA) or a summary (ER/IR).
2018-03-30 Polish
ZAWARCIE UMOWY O LINIĘ WIELOCELOWĄ WRAZ Z DOKUMENTAMI ZABEZPIECZENIA ORAZ ZAWARCIE ANEKSU DO UMOWY O LINIĘ FAKTORINGU ODWROTNEGO - Content (PL)
Capital/Financing Update Classification · 98% confidence The document text, written in Polish, details the signing of a multi-purpose credit line agreement (Umowa linii wielocelowej) between KRAKCHEMIA S.A. and Bank Ochrony Środowiska S.A. It specifies the credit limit (10,000,000 PLN), the types of credit (revolving credit, working capital loan), the term (until March 15, 2019), the purpose (financing current business needs), collateral, and interest rate structure (WIBOR 3M + Bank margin). It also mentions an amendment to a reverse factoring line agreement. This content directly relates to the company's financing activities and capital structure changes. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). The document cites Art. 17 ust 1 MAR, indicating it is a material event disclosure, but the subject matter is financing, not a general regulatory filing (RNS) or a report announcement (RPA).
2018-03-15 Polish
PODPISANIE ANEKSU DO UMOWY O LINIĘ FAKTORINGOWĄ Z PRAWEM REGRESU W OBROCIE KRAJOWYM - Content (PL)
Regulatory Filings Classification · 95% confidence The document is very short (533 characters) and announces the receipt of an annex (amendment) to an existing factoring agreement with a bank, extending the limit availability date. This is a specific corporate event disclosure related to financing/debt instruments. It is not a full report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). Since it is a specific regulatory disclosure about a material contract change, and it doesn't fit perfectly into Capital/Financing Update (CAP) which usually implies raising new capital, the most appropriate general category for specific, material, non-standard regulatory announcements is Regulatory Filings (RNS). It is a mandatory disclosure under MAR (Market Abuse Regulation), which often falls under general regulatory reporting.
2018-03-01 Polish
Informacja o wynikach przeprowadzonych testów na utratę wartości - Content (PL)
Earnings Release Classification · 99% confidence The document discusses the results of an impairment test (testy na utratę wartości) conducted on goodwill related to an acquired company (Maximex Sp. z o.o.), referencing IAS 36 (MSR 36). It details a specific write-down amount (-2,973 thousand PLN) due to a drop in sales volume. Although it mentions that the final impact will be presented in the 2017 financial statement, the core content is a specific accounting event related to asset valuation and impairment testing. This aligns best with the 'Audit Report / Information' category, which covers applied accounting principles and results of internal or regulatory stress tests, as impairment testing is a key component of the audit/accounting process, distinct from a full Annual Report (10-K) or a simple Earnings Release (ER). The document is a specific disclosure about an accounting event. FY 2017
2018-02-01 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.